University Hospital of Geneva-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier

    Translational Research, Vol. 181, pp. 83-95.e3